SynthesisPediatric endocrinology, diabetes, and metabolism2026
Changes in the diagnosis and management of polycystic ovary syndrome in adolescents based on recommendations of scientific societies over the last decade.
Synthesis in Pediatric endocrinology, diabetes, and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionhe paper presents a systematic review of current guidelines from scientific societies regarding polycystic ovary syndrome (PCOS) in adolescents published over the past decade. AIM OF THE STUDY: To summarize and compare recent international and national PCOS guidelines with emphasis on areas of consensus and divergence. MATERIAL AND
methodsA systematic review of guidelines published between 2015 and 2025 was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement. Ultimately, twelve documents containing adolescent-specific content were included.
resultsIn adolescents with PCOS, clinical symptoms of hyperandrogenism and menstrual irregularities are the main diagnostic criteria, whereas polycystic ovarian morphology and anti-Müllerian hormone concentration are not considered reliable indicators in adolescents. The current approach to PCOS also emphasizes the assessment and management of metabolic and psychological comorbidities.
conclusionsThe diagnosis and treatment of PCOS in girls require a separate approach related to age and ongoing puberty. According to the latest recommendations, lifestyle changes should be a mandatory part of therapy regardless of the background of the presented disorder. The pharmacological treatment should be tailored to the dominant symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.